These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetic/pharmacodynamic modeling of cortisol suppression after oral administration of fluocortolone. Rohatagi S, Täuber U, Richter K, Derendorf H. J Clin Pharmacol; 1996 Apr; 36(4):311-4. PubMed ID: 8728344 [Abstract] [Full Text] [Related]
3. Fluocortolone: pharmacokinetics and effect on ACTH and cortisol secretion during daily and alternate-day administration. Tüber U, Posern U, Bickel U, Matthes H, Voigt K. Eur J Clin Pharmacol; 1988 Apr; 35(2):177-81. PubMed ID: 2847930 [Abstract] [Full Text] [Related]
4. Fluocortolone: pharmacokinetics and effect on plasma cortisol level. Täuber U, Richter K, Matthes H. Eur J Clin Pharmacol; 1986 Apr; 30(4):433-8. PubMed ID: 3743619 [Abstract] [Full Text] [Related]
5. [Pharmacokinetics of fluocortolone in long term therapy of patients with rheumatic and hematologic diseases]. Lopatta F, Vecsei P, Täuber U, Haack D. Arzneimittelforschung; 1986 Aug; 36(8):1268-71. PubMed ID: 3490855 [Abstract] [Full Text] [Related]
6. Differential effects of hydrocortisone, fluocortolone, and aldosterone on nocturnal sleep in humans. Born J, Zwick A, Roth G, Fehm-Wolfsdorf G, Fehm HL. Acta Endocrinol (Copenh); 1987 Sep; 116(1):129-37. PubMed ID: 3661052 [Abstract] [Full Text] [Related]
7. [Binding of cortisol, fluocortolone and difluocortolone to human plasma proteins (author's transl)]. Fellier H, Gleispach H, Esterbauer H. J Clin Chem Clin Biochem; 1977 Oct; 15(10):545-8. PubMed ID: 925615 [Abstract] [Full Text] [Related]
8. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone. Chow FS, Sharma A, Jusko WJ. J Pharmacokinet Biopharm; 1999 Dec; 27(6):559-75. PubMed ID: 11153446 [Abstract] [Full Text] [Related]
9. Adrenocortical function after chronic inhalation of fluocortinbutyl and beclomethasone dipropionate. Vlasses PH, Ferguson RK, Koplin JR, Clementi RA, Green PJ. Clin Pharmacol Ther; 1981 May; 29(5):643-9. PubMed ID: 7214795 [Abstract] [Full Text] [Related]
10. [Study of the effects of HSDAD corticosteroid therapy on the diurnal rhythm of 11-OCHS secretion, cortisol metabolism, and calciuria in patients with myasthenia gravis. (Preliminary communication)]. Jusić A, Mikulicić V, Tajić M, Jurenić D. Neurologija; 1978 May; 26(1-4):63-6. PubMed ID: 572923 [No Abstract] [Full Text] [Related]
11. [The effect of fluocortin butylester on adrenal function in man (author's transl)]. Wendt H. Arzneimittelforschung; 1977 May; 27(11a):2236-8. PubMed ID: 580036 [Abstract] [Full Text] [Related]
12. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration. Täuber U, Haack D, Nieuweboer B, Kloss G, Vecsei P, Wendt H. Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661 [Abstract] [Full Text] [Related]
13. [Effect of topical glucocorticoids on endogenous cortisol production]. Neumann RA, Schmidt JB, Spona J. Z Hautkr; 1988 Apr 15; 63(4):302-8. PubMed ID: 3291439 [Abstract] [Full Text] [Related]
14. [The metabolism of hydrocortisone, prednisolone and fluocortolone (author's transl)]. Gleispach H, Porta S. Wien Klin Wochenschr; 1981 Nov 13; 93(21):671-3. PubMed ID: 7324480 [Abstract] [Full Text] [Related]
15. Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids. Meibohm B, Derendorf H, Möllmann H, Fröhlich P, Tromm A, Wagner M, Homrighausen S, Krieg M, Hochhaus G. Int J Clin Pharmacol Ther; 1999 Aug 13; 37(8):367-76. PubMed ID: 10475139 [Abstract] [Full Text] [Related]
18. Quantitative assay of the suppressive effect of synthetic corticoids in man. Evaluation of the circadian rhythm of serum cortisol after single oral doses of fluocortolone and prednisolone. Boss N, Kluge F, Müller OA, Pickardt CR, Scriba PC. Acta Endocrinol (Copenh); 1971 Jul 13; 67(3):508-16. PubMed ID: 5108731 [No Abstract] [Full Text] [Related]